Jaspreet Takhar

Jaspreet advises clients on complex issues at the intersection of healthcare, data and technology. Her practice has a particular focus on accessing and using patient data, innovative collaborations with hospitals, and the use and regulation of AI in the healthcare space.

Jaspreet regularly speaks at medtech and pharma industry trade association events on issues ranging from health data and innovation to medical research. She has contributed to white papers and policy work by the Association of the British HealthTech Industry (ABHI) and the UK’s Department of Health and Social Care, focussing on the future regulation of health data and fostering healthtech innovation in the UK.

• Advising various multinational companies on the development, regulation and supply of various AI-as-a-medical device products, including: licensing medical datasets from academic and medical institutions across the globe (for the purposes of training, testing and validating AI models); regulatory requirements under the EU AI Act, data protection laws and medical device laws; clinical research; and supply to hospitals.

• Advising sponsors and service providers on the regulatory hurdles in rolling out decentralised clinical trial elements across the globe, including remote monitoring of patients, home delivery of IMPs and deploying nurses for home visits (including data privacy issues, GCP and clinical trial regulation, and staffing models).

• Advising various multinational companies on developing responsible AI governance frameworks compatible with international regulation and best practices, including producing policies, risk assessment processes and documentation, governance forums, updating contracting terms with third parties, and providing training.

• Advising various multinational healthcare and life sciences companies on compliance with the EU AI Act, including identifying in-scope AI systems, supply chain designations and resulting compliance obligations. This includes advising on AI chatbots for patients, AI in clinical trials, AI in apps, and various other AI use cases.

• Advising a multinational tech company on its EU AI Act policy work, including counselling on the impact of various provisions on its product portfolio, suggested amendments to the text, and drafting talking points for policy teams when liaising with legislators on suggested amendments.

• Advising on innovative collaborations with NHS hospitals, including in connection with AI-related research, and setting up a new lab providing diagnostic services to other UK hospitals.

• Supporting a medtech company in contracting with NHS trusts and private hospitals across the UK for the supply of robotic surgical equipment, software and related consumables.

• Advising multinational healthcare and life sciences companies on establishing patient registries and associated contracting and regulatory requirements.

• Advising various multinational healthcare and life sciences companies on the use of patient data for a range of purposes, including for research and development of innovative technology, and for the provision of NHS-commissioned services.